Musculoskeletal/Rheumatology

Latest News

FDA Approves First Biosimilar of Arthritis Med Actemra
FDA Approves First Biosimilar of Arthritis Med Actemra

October 2nd 2023

Biogen is still evaluating launch timeline for Tofidence, and information on pricing will be available closer to launch.

Hyrimoz, a High-Concentration Humira Biosimilar, Approved by FDA

March 22nd 2023

FDA Approves Kevzara for Inflammatory Rheumatic Disease
FDA Approves Kevzara for Inflammatory Rheumatic Disease

March 1st 2023

 Will the Biosimilar Amjevita Lower Costs?
Will the Biosimilar Amjevita Lower Costs?

February 2nd 2023

First Humira Biosimilar is Now Available
First Humira Biosimilar is Now Available

January 31st 2023

Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.